Alfred O. Mueck

No ORCID on file · 16 papers in corpus · active 1996-2020

Study types

  • article 13
  • erratum 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 6
  • mesh:D004715 2
  • dysmenorrhea 1
  • endometrioma 1
preprint 2020
·doi:10.21203/rs.2.23689/v1

Abstract Purpose Until now, it is not clear how much total ovarian tissue can be removed without affecting ovarian functions. Aim to investigate impact of stepwise removed ovarian tissue on endocrine hormone levels reflecting ovarian functi…

article 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2018.1549220

Objective: To investigate temporary or long-term changes of AMH after laparoscopic endometrioma cystectomy and its dependency on characteristics of endometriomas.Methods: One hundred and seventy-one women, open-labeled prospective study; fi…

article 2017
·doi:10.1016/j.maturitas.2017.03.066
article 2015
·doi:10.1016/j.maturitas.2015.02.061
article 2012
·doi:10.3109/09513590.2012.730572

OBJECTIVES: Dienogest (DNG) is already used in hormone therapy, since recently being also the progestogenic component of the first estradiol based contraceptive pill. Data on breast cancer risk are currently not available. Progesterone rece…

erratum 2011
·doi:10.1016/j.ijgo.2010.12.001

The authors wish to clarify that analyses in the paper are based on the full-analysis set (FAS), excluding patients for whom data were unavailable. For the revised American Fertility Society (rAFS) score, data were unavailable in 9.5% of pa…

article 2010
·doi:10.1586/eog.10.71

Dienogest is a progestogen that combines the pharmacological properties of 19-norprogestins and progesterone derivatives. Dienogest has a potent effect on endometrial tissue, producing antiproliferative effects on endometriotic cells, as we…

article 2010
Hormone molecular biology and clinical investigation ·doi:10.1515/hmbci.2010.061

New research on mechanisms of progestin effects in endometriosis treatment has been performed with dienogest (DNG), which has recently been launched in this regard. It is effective in the same low dosage of 2 mg/day, similar to the use of c…

article 2010
·doi:10.3109/09513590903184167

Dienogest (DNG) has the essential properties of an effective progestogen for use in a new contraceptive pill using estradiol valerate as estrogenic component -- it inhibits ovulation and protects against endometrial proliferation. DNG is a …

article 2009
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2009.08.020

OBJECTIVES: To compare the efficacy and safety of dienogest at doses of 1, 2, and 4mg/day orally in the treatment of endometriosis. METHODS: An open-label, randomized, multicenter, 24-week comparative trial in women with histologically conf…

review 2009
Therapeutische Umschau. Revue therapeutique ·doi:10.1024/0040-5930.66.2.101

Surveys show that most women desire a change in their menstrual pattern in the sense that they would prefer less menstruations or even amenorrhea. On this behalf, there is no difference between women having spontaneous natural cycles and wo…

article 2009
·doi:10.1080/09513590903184167
article 2007
·doi:10.1016/j.maturitas.2007.01.001
article 2002
·doi:10.1016/s0378-5122(02)00160-3
article 2001
·doi:10.1016/s0378-5122(01)00169-4
article 1996
·doi:10.1097/00042192-199603010-00007

The effect of estradiol, progesterone, and three progestogens on calcium influx was investigated in cell cultures of human vessels under resting conditions. Estradiol significantly inhibited calcium influx in endothelial and smooth muscle c…